The Minimum Clinically Important Difference of the Incremental Shuttle Walk Test in Bronchiectasis: A Prospective Cohort Study

Jessica A. Walsh, Suhani Patel, Ruth E Barker, Sarah E. Jones, Stephanie C Wynne, Samantha S.c. Kon, Julius Cairn, Michael R. Loebinger, Robert C. Wilson, William D‐c Man, Claire M. NolanAnnals 2019 · DOI · OpenAlex

Abstract

The incremental shuttle walk test (ISW) is an externally-paced field walking test that measures maximal exercise capacity1 and is widely used in patients with chronic obstructive pulmonary disease (COPD) undergoing pulmonary rehabilitation (PR). Its psychometric properties, including reliability, construct validity2 and responsiveness to intervention,2-5 have been demonstrated in patients with bronchiectasis, but little data exist on the minimum clinically important difference (MCID). Although two studies have investigated the MCID of ISW in patients with bronchiectasis, the generalisability of these data is limited because of the study sample characteristics,6 or did not involve an exercise-based intervention.2 The MCID enables clinicians and researchers to understand the clinical significance of change data and forms an important part of the evidence required by regulatory agencies for approval for use in clinical trials. Accordingly, the aim of this study was to provide MCID estimates of the ISW in response to intervention, namely PR, in patients with bronchiectasis.
BibTeX
@article{walsh2019minimum,
  author = {Jessica A. Walsh and Suhani Patel and Ruth E Barker and Sarah E. Jones and Stephanie C Wynne and Samantha S.C. Kon and Julius Cairn and Michael R. Loebinger and Robert C. Wilson and William D‐C Man and Claire M. Nolan},
  title = {{The Minimum Clinically Important Difference of the Incremental Shuttle Walk Test in Bronchiectasis: A Prospective Cohort Study}},
  journal = {Annals},
  year = {2019},
  doi = {10.1513/annalsats.201907-563rl},
}

Loading related content...

Figure